We are live on ! Find out more
COCH icon

Envoy Medical
COCH

93 hedge funds and large institutions have $368M invested in Envoy Medical in 2022 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 20 increasing their positions, 13 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more funds holding in top 10

Funds holding in top 10: 1 → 2 (+1)

54% more repeat investments, than reductions

Existing positions increased: 20 | Existing positions reduced: 13

2% more capital invested

Capital invested by funds: $362M → $368M (+$6.67M)

7% less first-time investments, than exits

New positions opened: 14 | Existing positions closed: 15

1% less funds holding

Funds holding: 94 → 93 (-1)

1.13% less ownership

Funds ownership: 87.31% → 86.18% (-1.1%)

Holders
93
Holders Change
-1
Holders Change %
-1.06%
% of All Funds
1.49%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.03%
New
14
Increased
20
Reduced
13
Closed
15
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
KIM
Karpus Investment Management
New York
+$9.02M
2
Jane Street
Jane Street
New York
+$5.21M
3
CIM
Cowen Investment Management
New York
+$3.48M
4
Calamos Advisors
Calamos Advisors
Illinois
+$2.98M
5
RCM
Rivernorth Capital Management
Florida
+$2.6M

Top Sellers

Rank Fund Capital Flow
1
GCL
Glazer Capital LLC
New York
-$34M
2
BNP Paribas Financial Markets
BNP Paribas Financial Markets
France
-$8.37M
3
UOC
UBS O'Connor
Illinois
-$4.2M
4
HCM
Highbridge Capital Management
New York
-$2.95M
5
CF
Cantor Fitzgerald
New York
-$2.88M
Name Holding Trade Value Shares
Change 		Change in
Stake
AA
26
AQR Arbitrage
Connecticut
$4.94M +$675K +67,875 +16%
WP
27
Woodline Partners
California
$4.76M – – –
LA
28
Linden Advisors
New York
$3.99M – – –
FTCM
29
First Trust Capital Management
Illinois
$3.8M +$237K +23,876 +7%
CIM
30
Cowen Investment Management
New York
$3.51M +$3.48M +350,000 New
DCM
31
Difesa Capital Management
New York
$3.15M – – –
DCM
32
Dupont Capital Management
Delaware
$3.03M – – –
Calamos Advisors
33
Calamos Advisors
Illinois
$3.03M +$2.98M +300,000 New
BCM
34
BlueCrest Capital Management
Jersey
$3.01M – – –
CCA
35
Castle Creek Arbitrage
Colorado
$2.94M – – –
Janus Henderson Group
36
Janus Henderson Group
United Kingdom
$2.79M +$1.49M +149,778 +117%
State of Wisconsin Investment Board
37
State of Wisconsin Investment Board
Wisconsin
$2.68M – – –
DFCM
38
Dark Forest Capital Management
Puerto Rico
$2.62M +$2.45M +246,045 +1,553%
RCM
39
Rivernorth Capital Management
Florida
$2.62M +$2.6M +261,300 New
ETH
40
Exos TFP Holdings
New York
$2.57M +$2.55M +256,800 New
AIMCA
41
Alberta Investment Management Corp (AIMCo)
Alberta, Canada
$2.52M – – –
CSS
42
Cubist Systematic Strategies
Connecticut
$2.51M +$184K +18,543 +8%
PSAMP
43
P. Schoenfeld Asset Management (PSAM)
New York
$2.1M +$2.08M +209,550 New
Goldman Sachs
44
Goldman Sachs
New York
$2.01M +$298 +30 +0%
Capstone Investment Advisors
45
Capstone Investment Advisors
New York
$2M – – –
GL
46
Governors Lane
New York
$2M – – –
SOA
47
Sea Otter Advisors
Florida
$1.92M +$1.9M +191,293 New
WAM
48
Wolverine Asset Management
Illinois
$1.91M -$276K -27,730 -13%
GCM
49
Ghisallo Capital Management
Massachusetts
$1.89M -$20 -2 -0%
ASM
50
ATW SPAC Management
New York
$1.75M – – –
1
2
3 4 5

COCH Hedge Fund Activity: Q4 2022 in Review

93 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Envoy Medical (COCH) for Q4 2022, worth a combined $368M — up 1.8% from $362M a quarter earlier.

Sellers outnumbered buyers: 15 funds closed out of COCH and 14 opened new positions — a net loss of 1 holder — while 13 trimmed existing stakes and 20 added.

The largest buyer was Karpus Investment Management, adding an estimated $9.02M. The largest seller was Glazer Capital LLC, cutting an estimated $34M.

  • 93 institutional investors held Envoy Medical (COCH) as of Q4 2022, down from 94 in Q3 2022.
  • Funds reported $368M of Envoy Medical stock for Q4 2022, up 1.8% quarter-over-quarter.
  • 14 funds opened new Envoy Medical positions in Q4 2022 and 15 closed out, a net change of -1 holder.
  • The largest Envoy Medical buyer in Q4 2022 was Karpus Investment Management, an estimated $9.02M added.
  • The largest Envoy Medical seller in Q4 2022 was Glazer Capital LLC, an estimated $34M sold.

Based on aggregated 13F filings for Q4 2022.